A study on the pharmaceutical companies of DSE listed firms of Bangladesh for the period of 2018 to 2022
This internship report is submitted in partial fulfillment of the requirements for the degree of Bachelor of Business Administration, 2023.
Príomhchruthaitheoir: | Sushme, Sumaiya Selim |
---|---|
Rannpháirtithe: | Haque, Mohammad Mujibul |
Formáid: | Internship report |
Teanga: | English |
Foilsithe / Cruthaithe: |
Brac University
2024
|
Ábhair: | |
Rochtain ar líne: | http://hdl.handle.net/10361/22882 |
Míreanna comhchosúla
-
Disclosure and compliance of IAS 16 in DSE listed pharmaceuticals companies in Bangladesh
de réir: Al-Mumen, Sk. Abdullah
Foilsithe / Cruthaithe: (2018) -
Empirical evidence of CAPM model at pharmaceutical industry of DSE
de réir: Islam, Md. Tariqul
Foilsithe / Cruthaithe: (2024) -
Response of market price relative to fundamentals of stocks : a case based approach on pharmaceutical industry listed in DSE
de réir: Faruquee, Murtaza
Foilsithe / Cruthaithe: (2013) -
Empirical analysis of 5 DSE equity traded through IDLC Investments Ltd & portfolio management
de réir: Ismail, Mohammed
Foilsithe / Cruthaithe: (2017) -
In-plant training at Healthcare Pharmaceuticals Limited
de réir: Rashid, Nowrin, et al.
Foilsithe / Cruthaithe: (2021)